| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6062620 | Journal of Allergy and Clinical Immunology | 2016 | 23 Pages |
Abstract
Risk stratification based on the severity of the initial HSR and skin testing to guide taxane reintroduction is safe and allows a significant number of patients to resume regular infusions.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Matthieu MD, Leyla MD, Joana MD, Pedro MD, PhD, Violeta Regnier MD, Suzanne T. DO, Susana M. MD, Ursula A. MD, Mariana C. MD, PhD,